Keywords
Phyllanthus emblica
Glycyrrhiza glabra
pre-compression parameters
post-compression parameters
in vitro drug release
acid-neutralizing capacity
Abstract
Polyherbal chewable tablets of Phyllanthus emblica and Glycyrrhiza glabra were developed with the objective to formulate an effective, safe and convenient dosage form for acid-related disorders. A standard calibration curve was constructed for Polyherbal extracts through UV-Spectrophotometry, achieving an absorbance maximum at 275 nm. Compatibility between the drug and excipients was examined through FTIR studies. Various pre-compression parameters, like bulk density, tapped density, compressibility index, Hausner’s ratio and angle of repose, were assessed for the powder blend. The tablets were evaluated for post-compression parameters, such as thickness, hardness, friability, and weight variation and disintegration time. The drug release study was conducted in vitro. The acid-neutralizing capacity of the formulated batches was compared with marketed formulations. The calibration curve showed a high correlation coefficient (r2=0.9972), suggesting accuracy and reliability. FTIR analysis confirmed the compatibility between the drug and excipients. Pre-compression studies revealed an acceptable range for all parameters, indicating good flow properties. For instance, Carr's Index for all batches varied from 14.31% to 24.41%, and the angle of repose ranged from 33.7 to 35.21 degrees. Post-compression parameters were within the standard limits with hardness between 4.9 to 6.1 kg/cm2 and friability less than 1% for all batches. In vitro drug release showed a gradual increase over time with PF9 achieving 98.63% release at 60 min. The acid-neutralization capacity was highest for the combined extract at 27.83±0.34 mEq/g and PF9 batch at 28.12±0.43 mEq/g, demonstrating their effectiveness in neutralizing acid.
The study successfully formulated a Polyherbal chewable tablet with optimized pre and post-compression parameters. The tablet exhibited promising in vitro drug release and an efficient acid-neutralizing capacity. It holds potential as an effective treatment option for acid-related disorders.
References
1. Sharma S, Sharma P, Katiyar D, Goel R, Sahoo J. Formulation, standardization and screening of polyherbal churna for antacid activity. Int J Res Ayurveda Pharm. 2018;9(4):94-7.
2. Ramana VK, R VK, Rsnakk C, Subhadra S, Professor A. Assessment of in vitro antacid activity of different root extracts of Tephrosia purpurea (L) pers by modified artificial stomach model. Asian Pac J Trop Biomed. 2012:2(3):1487-92.
3. https://nativecare.icliniq.com/articles/gastro-health/hyperacidity
4. Reddy AS, Reddy DRK, Prasad NAV. Herbal and pharmaceutical drugs enhanced with probiotics. United States Patent; 2000;44-87.
5. Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: Concept of Ayurveda. Pharmacogn Rev. 2014;8:73-80.
6. Michele TM, Knorr B, Vadas EB, Reiss TF. Safety of chewable tablets for children. Ann Pharmacother. 2002;36(3):391-403.
7. Strickley RG, Iwata Q, Wu S, Dahl TC. Pediatric drugs – a review of commercially available oral formulations. J Pharm Sci. 2008;97(5):1731-74.
8. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. CBS Publishers & Distributors; 2009:182-303.
9. Kushwaha SK, Jain A, Jain A, Gupta VB, Patel JR. Hepatoprotective activity of the fruits of Momordica dioica. Niger J Nat Prod Med. 2005;9:29-31.
10. Singh E, Sharma S, Pareek A, Yadav S, Sharma S, Dwivedi J. Phyto-chemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The sustainer. J Appl Pharm Sci. 2011; 2(01):176-83.
11. Khan KH. Role of Emblica officinalis in medicine-a review. Bot Res Int. 2009;2(4):218-28.
12. Jayaweera DMA. Medicinal plants (indigenous and exotic) used in Ceylon: Acanthaceae-Burseraceae. Colombo: National Science Council of Sri Lanka. 1980;4(2).
13. Talreja S, Kumari S, Srivastava P, Pandey S. A complete pharma-cognostic review on amla. World J Pharm Pharm Sci. 2020;(4):622-37.
14. Ch SVK. Lycopene: Advancement in functional food ingredients (book chapter). 2nd ed. 2019:78.
15. Nesar A, Noorul H, Khalid M, Juber A, Mujahid M, Badruddin, et al. Glycyrrhiza glabra: traditional uses and pharmacological actions. Adv J Pharm Life Sci Res. 2016;4(2):23-32.
16. Damle M. Glycyrrhiza glabra (Liquorice) – a potent medicinal herb. Int J Herb Med. 2014;2(2):132-6.
17. Kaur R, Kaur H, Dhindsa AS. Glycyrrhiza glabra: A phyto-pharmacological review. Int J Pharm Sci Res. 2013;4(7):2470-7.
18. Tewari D, Mocan A, Parvanov ED, Sah AN, Nabavi SM, Huminiecki L, et al. Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families. Front Pharmacol. 2017;8.
19. Khare C. Encyclopedia of Indian Medicinal Plants. Nyw York: Springer; 2004:233-5.
20. Indian Pharmacopoeia. Indian Pharmacopoeial Commission, Ghaziabad: Government of India. Ministry of Health and Family Welfare; 2014:3174-6, 3282-84.
21. WHO. Quality control methods for medicinal plant materials. Geneva: World Health Organization; 1998.
22. Bunaciu AA, Aboul-Enein HY, Fleschin S. Application of Fourier transform infrared spectrophotometry in pharmaceutical drugs analysis. Appl Spectrosc Rev. 2010;45(3):206-19.
23. Mallik S, Kshirsagar MD, Saini V. Studies on physical/chemical compatibility between synthetic and herbal drugs with various pharmaceutical excipients. Sch Res Libr. 2011;3(5):173-8.
24. United States Pharmacopoeia (USP34 NF29). Rockville: The United States Pharmacopeial Convention;2011:140-1.
25. Verma PRP, Shrivastava A, Pathria A. In vitro evaluation of some ayurvedic antacids. Anc Sci Life. 1996; XVI(2):152-5
26. Sunilson AJ, Said RB, Anandarajagopal K, Gnana Kumari A, Vimala A, Khan A, et al. Formulation and evaluation of herbal capsules containing dried ethanol extract of Gnetum gnemon fruits. Int J Pharm Pharm Res. 2018;12(1):273-80.
27. Banik B, Sharma A, Nasrin A. Development and evaluation of carminative herbal chewable tablets based on turmeric, fennel seed, and mango ginger. Asian Pac J Health Sci. 2021;8(3):141-5.
28. Aulton ME, Taylor KMG. Aulton's Pharmaceutics. Vol. 3. Churchill Livingstone; 2007:176-8.
29. Balekundri A, Shahapuri A, Patil M. Poly-herbal tablet formulation by design expert tool and in vitro anti-lipase activity. Futur J Pharm Sci. 2020;6(1).
30. Anonymous: Indian Pharmacopoeia. Government of India, Ministry of Health and Family Welfare. New Delhi: Controller of Publication; 2007.
31. Singla S, Kumari P, Rana R, Thakur R, Goyal S. Formulation and evaluation of polyherbal tablets for management of osteoporosis. J Bio Innov. 2022;11(2):320-33.
32. Sahoo HB, Asati AK, Toppo FA, Kori ML. Evaluation of polyherbal formulation for diuretic activity in albino rats. Asian Pac J Trop Dis. 2012;2(11):442-5.
33. Indian Pharmacopoeia. Indian Pharmacopoeia Commission, Ghaziabad: Government of India. Ministry of Health and Family Welfare; 2010:819-20.
34. Osei-Asare C, Owusu FWA, Entsie P, Annan AK. Formulation and in vitro evaluation of oral capsules from liquid herbal antimalarials marketed in Ghana. J Trop Med. 2021;1-9.
35. Alalor CA, Avbunudiogba JA, Builders FP, Okpara LO. Biological standardization of some polyherbal formulations for antacid activity. East Afr Sch J Med Sci. 2019;2(1):12-6.
36. Suvarna I, Kumari A, Jeenal P, Tejas P, Pramod I. Biological standardization of some polyherbal formulations for antacid activity. Sch Res Libr. 2014;6(1):83-6.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2024 Authors